IP Library Granted Patent US 12,038,444
Granted Patent B2
US 12,038,444 · App. 17/828,465 · Granted Jul 16, 2024

Pseudo-electropherogram construction from peptide level mass spectrometry data

Inventors: Andrew Nichols (Redwood City, CA); Marshall Bern (San Carlos, CA); Yong Joo Kil (Fremont, CA); Eric Carlson (Cupertino, CA)
Assignee: Protein Metrics, LLC
G01N33/6848H01J49/0036H01J49/004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,038,444
App. No.
17/828,465
Granted
Jul 16, 2024
Kind
B2
Abstract

Methods and apparatuses for the identification and/or characterization of properties of a macromolecule based on mass spectrometry data. Specifically, described herein are methods and apparatuses for converting peptide-level data into a pseudo-intact mass spectra. Also described herein are methods and apparatuses for converting peptide-level data into a pseudo-electropherogram. The methods may be well suited for analyzing proteins and protein complexes, including estimating properties of post-translational modifications of the proteins and protein complexes. Methods may include generating a theoretical graph or spectrum based on peptide-level mass spectrometry data. In some embodiments, the theoretical graph may be a theoretical intact mass spectrum or a theoretical charge distribution spectrum.

Claims (34)

1. A method for generating a pseudo-electropherogram of a protein or protein complex, the method comprising:

receiving peptide-level mass spectrometry data including mass-to-charge ratio data associated with peptides of the protein or protein complex, wherein the mass-to-charge ratio data includes mass-to-charge ratio data associated with modified peptide forms;

generating the pseudo-electropherogram based on all or a subset of the modified peptide forms, wherein generating the pseudo-electropherogram comprises:

determining masses of the modified peptide forms based on the mass-to-charge ratio data associated with the modified peptide forms,

matching reference peptide sequences of the protein or protein complex against the determined masses of the modified peptide forms to map the modified peptide forms to locations in the protein or protein complex, and

combining calculated charge distributions of the modified peptide forms calculated based on isoelectric point to generate a distribution of charge variant forms of the protein or protein complex; and

displaying the pseudo-electropherogram representing different charge variant forms of the protein or protein complex.

2. The method of claim 1 , wherein the reference peptide sequences are in a reference list of peptide sequences.

3. The method of claim 1 , wherein generating the pseudo-electropherogram includes estimating a relative abundance of each of the modified peptide forms based on mass spectrometric measurements of each corresponding modified peptide form.

4. The method of claim 1 , wherein generating the pseudo-electropherogram includes charge normalizing one or more modification groups of the modified peptide forms.

5. The method of claim 1 , wherein displaying the pseudo-electropherogram includes displaying an overlay of an experimentally-derived electropherogram with the pseudo-electropherogram.

6. The method of claim 5 , wherein a peak associated with the protein in the experimentally-derived electropherogram is aligned with a peak associated with a corresponding protein in the pseudo-electropherogram.

7. The method of claim 5 , wherein the experimentally-derived electropherogram includes capillary isoelectric focusing (ciEF) electropherogram data.

8. The method of claim 1 , wherein the modified peptide forms include one or more modification groups, the one or more modification groups including one or more of a glycan group, a phosphate group, an amino group and a carboxyl group.

9. The method of claim 1 , further comprising generating a pseudo-intact mass spectrum based on all or a subset of the modified peptide forms, and displaying the pseudo-intact mass spectrum to a user.

10. The method of claim 9 , further comprising displaying the pseudo-electropherogram in a first window of a user interface and displaying the pseudo-intact mass spectrum in a second window of the user interface.

11. The method of claim 5 , further comprising displaying one or more labels on or near a peak of the pseudo-electropherogram or the experimentally-derived electropherogram.

12. The method of claim 1 , wherein the peptide-level mass spectrometry data is based on an enzyme-digested sample of the protein or protein complex.

13. A system, the system comprising:

one or more processors; and

a memory coupled to the one or more processors, the memory configured to store computer-program instructions, that, when executed by the one or more processors, perform a computer-implemented method comprising:

receiving peptide-level mass spectrometry data including mass-to-charge ratio data associated with peptides of a protein or protein complex, wherein the mass-to-charge ratio data includes mass-to-charge ratio data associated with modified peptide forms;

generating a pseudo-electropherogram based on all or a subset of the modified peptide forms, wherein generating the pseudo-electropherogram comprises:

determining masses of the modified peptide forms based on the mass-to-charge ratio data associated with the modified peptide forms,

matching reference peptide sequences of the protein or protein complex against the determined masses of the modified peptide forms to map the modified peptide forms to locations in the protein or protein complex, and

combining calculated charge distributions of the modified peptide forms calculated based on isoelectric point to generate a distribution of charge variant forms of the protein or protein complex; and

displaying the pseudo-electropherogram to a user, wherein the pseudo-electropherogram represents different charge variant forms of the protein or protein complex.

14. The system of claim 13 , wherein generating the pseudo-electropherogram includes charge normalizing one or more modification groups of the modified peptide forms, wherein generating the pseudo-electropherogram is based on different charge states of the modified peptide forms.

15. The system of claim 13 , wherein the reference peptide sequences are in a reference list of peptide sequences.

16. The system of claim 13 , wherein generating the pseudo-electropherogram includes predicting a relative abundance of each of the modified peptide forms based on a mass spectrometric measurement associated with each corresponding modified peptide form.

17. The system of claim 13 , wherein displaying the pseudo-electropherogram includes displaying an overlay of an experimentally-derived electropherogram with the pseudo-electropherogram.

18. The system of claim 17 , wherein a peak associated with a modified peptide form having in the experimentally-derived electropherogram is aligned with a peak associated with a corresponding modified peptide form in the pseudo-electropherogram.

19. The system of claim 13 , wherein the modified peptide forms include one or more modification groups, the one or more modification groups including one or more of a glycan group, a phosphate group, an amino group and a carboxyl group.

20. The system of claim 13 , wherein the computer-implemented method further comprises generating a pseudo-intact mass spectrum based on all or a subset of the modified peptide forms, and displaying the pseudo-intact mass spectrum to the user.

Assignments (7)
SECURITY INTEREST Recorded Jan 20, 2026
From: PROTEIN METRICS, INC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 073520/0183 →
RELEASE OF SECURITY INTEREST Recorded Jan 20, 2026
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: PROTEIN METRICS, INC.
Reel/Frame 073521/0221 →
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2025
From: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
To: PROTEIN METRICS, LLC; SOFTGENETICS, LLC
Reel/Frame 071582/0907 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jul 1, 2024
From: PROTEIN METRICS, LLC; SOFTGENETICS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 068102/0180 →
CHANGE OF ADDRESS FROM CUPERTINO, CA TO BOSTON, MA. Recorded Jun 5, 2024
From: PROTEIN METRICS, LLC
To: PROTEIN METRICS, LLC
Reel/Frame 067637/0766 →
CHANGE OF NAME Recorded Feb 8, 2023
From: PROTEIN METRICS INC.
To: PROTEIN METRICS, LLC
Reel/Frame 062625/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2022
From: NICHOLS, ANDREW; BERN, MARSHALL; KIL, YONG JOO; CARLSON, ERIC
To: PROTEIN METRICS INC.
Reel/Frame 060059/0357 →
Continuity (3)
Continuation 16859758 · Apr 27, 2020
Provisional Application 62839507 · Apr 26, 2019
Related Publication 20220291229A1 · Sep 15, 2022
Cited By (1)
US 12,352,757